Product
5% Glucose
4 clinical trials
11 indications
Indication
SepsisIndication
Sepsis-Induced CoagulopathyIndication
Nafamostat MesilateIndication
Acute Heart FailureIndication
Upper respiratory congestionIndication
Congestive Heart FailureIndication
Transesophageal EchocardiographyIndication
Acute Respiratory Distress SyndromeIndication
Right Ventricular DysfunctionIndication
Septic shockIndication
Vasopressor ResistanceClinical trial
Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy: a Multicenter Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2026-10-01
Clinical trial
The Impact of Slow, Continuous Infusion of Sodium Chloride or Glucose Solution on Diuresis and Urine Composition During Decongestion of Acute Heart Failure PatientsStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Using Transesophageal Echocardiography to Evaluate the Effect of Levosimendan on Patients With Acute Respiratory Distress Syndrome Associated With Right Ventricular Dysfunction During Mechanical VentilationStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Randomized Controlled Pilot Study Evaluating the Effect of Dexmedetomidine on Phenylephrine Response During Refractory Septic ShockStatus: Terminated, Estimated PCD: 2023-01-31